Kevin Hale Black, DDS, MD | |
1000 Blythe Blvd, Charlotte, NC 28203-5812 | |
(704) 355-2000 | |
Not Available |
Full Name | Kevin Hale Black |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1000 Blythe Blvd, Charlotte, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003995085 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 19705 (Texas) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kevin Hale Black, DDS, MD Po Box 32861, Charlotte, NC 28232-2861 Ph: (704) 355-2000 | Kevin Hale Black, DDS, MD 1000 Blythe Blvd, Charlotte, NC 28203-5812 Ph: (704) 355-2000 |
News Archive
The results of a survey were published on the medRxiv* preprint server, the purpose of which was to assess the relative well-being of the population under Covid-19 restrictions – through 952 survey respondents from France, India, Italy, the UK, and the US.
Three out of four patients treated with an experimental combination of three different therapies for the rare skin cancer known as Merkel cell carcinoma are in complete remission following the treatment, according to study results from a small clinical trial led at Fred Hutchinson Cancer Research Center.
Doctors have reported that partial or total loss of the sense of smell is often an early symptom of infection with SARS-CoV-2, the virus that causes COVID-19.
"President Barack Obama's 'perfect choice' for state secretary" - Sen. John Kerry (D-Mass.) - "is not only expected to advance the administration's agenda on global health and food security, but he might also lend new heft to efforts to rein in climate change, one of Kerry's long-time priorities, with a team of advisers that is expected to include several with a background in international development," Devex reports.
Combination treatment with umeclidinium plus vilanterol improves lung function in patients with chronic obstructive pulmonary disease to a greater extent than with VI or tiotropium monotherapy, results show.
› Verified 7 days ago